Information  X 
Enter a valid email address

Medaphor Group PLC (MED)

  Print      Mail a friend       Annual reports

Thursday 13 December, 2018

Medaphor Group PLC

Director/PDMR Shareholding

RNS Number : 3741K
Medaphor Group PLC
13 December 2018
 

13 December 2018

 

 

MedaPhor Group plc

 

("MedaPhor" or the "Group" or the "Company")

 

Director and PCA Dealings

 

 

Further to the Company's announcements on 26 November 2018 and 12 December 2018, MedaPhor announces that certain Directors, persons closely associated ("PCA") with them and an employee have, following Admission today, acquired a total of 1,847,064 ordinary shares of 1 pence each in the Company ("Ordinary Shares") via the Placing:

 

 

Name

Title

Number of Placing Shares subscribed for

Value of Placing Shares subscribed for

Resulting shareholding following subscription

Percentage of enlarged share capital following subscription

Riccardo Pigliucci

Non-Executive Chairman

117,648

£   10,000.08

117,648

0.1%

Stuart Gall

Chief Executive Officer

588,236

£   50,000.06

628,236

0.4%

Wilson Jennings

Finance Director

294,118

£   25,000.03

294,118

0.2%

Nicholas Sleep

Chief Technology Officer

176,471

£   15,000.04

226,471

0.1%

Ian Whittaker

Chief Operating Officer

117,648

£   10,000.08

349,982

0.2%

Nick Avis*

Non-Executive Director

141,177

£   12,000.06

341,177

0.2%

Andrew Barker

Non-Executive Director

117,648

£   10,000.08

317,992

0.2%

 

* Nick Avis' subscription has been made via his children: Alice Avis, Florence Avis and Harriet Avis who have each subscribed for 47,059 Placing Shares. Alice, Florence and Harriet are considered to be persons closely associated with Nick Avis.

 

 

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

 

 

1.   Riccardo Pigliucci

2.   Stuart Gall

3.   Wilson Jennings

4.   Nicholas Sleep

5.   Ian Whittaker

6.   Alice Avis

7.   Florence Avis

8.   Harriet Avis

9.   Andrew Barker

2

Reason for the notification

a)

 

Position/status

 

 

1.   Non-Executive Chairman

2.   Chief Executive Officer

3.   Finance Director

4.   Chief Technology Officer

5.   Chief Operating Officer

6.   Person closely associated with Nick Avis (Non-Executive Director)

7.   Person closely associated with Nick Avis (Non-Executive Director)

8.   Person closely associated with Nick Avis (Non-Executive Director)

9.   Non-Executive Director

b)

Initial notification /Amendment

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

MedaPhor Group plc

b)

LEI

213800K4ZVWL4ZYQAZ70

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

 

Identification code

Ordinary Shares of 1 pence each

 

 

ISIN: GB00BN791Q39

b)

Nature of the transaction

Purchase of Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

1.   8.5 pence

2.   8.5 pence

3.   8.5 pence

4.   8.5 pence

5.   8.5 pence

6.   8.5 pence

7.   8.5 pence

8.   8.5 pence

9.   8.5 pence

 

1.   117,648

2.   588,236

3.   294,118

4.   176,471

5.   117,648

6.   47,059

7.   47,059

8.   47,059

9.   117,648

d)

Aggregated information

- Aggregated volume

- Price

 

N/A - single transaction

e)

Date of the transaction

13 December 2018

f)

Place of the transaction

London Stock Exchange, XLON


Enquiries:

MedaPhor Group plc 

www.medaphor.com

Stuart Gall, CEO 
Wilson Jennings, CFO

Tel: +44 (0)29 2075 6534 



Cenkos Securities - Nominated Advisor and broker

Tel:  +44 (0)20 7397 8900 

Mark Connelly / Cameron MacRitchie (Corporate Finance)


Michael Johnson / Julian Morse (Sales) 




Walbrook PR 

Tel: +44 (0)20 7933 8780 or [email protected] 

Anna Dunphy / Paul McManus 

Mob: +44 (0)7876 741 001 / Mob: +44 (0)7980 541 893

 

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHLIFFTFTLVLIT

a d v e r t i s e m e n t